|Home | About | Journals | Submit | Contact Us | Français|
Anyone in the neuro-oncology profession may submit to the journal announcements of meetings and funding opportunities of interest to colleagues. Please send announcements to Oliver Bögler, Ph.D., Brain Tumor Center and Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, Unit BSRB 1004, Room S5.8136, 1515 Holcombe Boulevard, Houston, TX 77030, USA (telephone: 713-834-6216; fax: 713-834-6257; e-mail: gro.cno-oruen-cos@swenyteicos).
Correspondence to the Society should be sent to Society for Neuro-Oncology, P.O. Box 890886, Houston, TX 77289-0886, USA, or in care of Jan Esenwein, 4617 Birch Street, Bellaire, TX 77401-5509, USA (telephone: 713-349-0952; fax: 832-201-8129; e-mail: gro.cno-oruen-cos@naj or gro.cno-oruen-cos@pihsrebmem).
Following the recent elections, the SNO officers are as follows:
President: Abhijit Guha ( firstname.lastname@example.org)
Vice President: Mark R. Gilbert ( gro.nosrednadm@trebligrm)
Secretary-Treasurer: Corey Raffel ( email@example.com)
Board of Directors: Timothy Cloughesy, Jonathan Finlay, Frederick F. Lang, Glenn Lesser, David N. Louis, Minesh P. Mehta, Christina A. Meyers, Erwin Van Meir
Past President: Michael D. Prados ( ude.fscu.oruen@msodarp)
Journal Editor in Chief: Darell D. Bigner
Committee Chairs: Awards, Michael Berens; Bylaws, Kurt A. Jaeckle; Communications, Oliver Bögler; Education, Frederick F. Lang; Future Sites, Walter Hall
Staff: Jan Esenwein, SNO Headquarters
Announcement is made of the position of Editor in Chief of Neuro-Oncology. The Editor in Chief ensures high scientific standards and balance in the journal’s contents, which include basic, translational, and clinical science, consistent with the goals of the Society for Neuro-Oncology. The Editor also determines journal policy and long-range goals in consultation with SNO and the journal’s Editorial Board. The ideal candidate is a mature senior scientist who holds M.D. and Ph.D. degrees or the equivalent and has extensive experience in the field of neuro-oncology, with an international reputation for his or her own work. The candidate for this position should be a seasoned reviewer of manuscripts and should have served on multiple editorial boards of other oncology and neuroscience journals. Administrative experience, including financial management of complex projects, is essential. Candidates for Editor in Chief should send a letter of interest and curriculum vitae to SNO, c/o Jan Esenwein, 4617 Birch Street, Bellaire, TX 77401-5509 ( gro.cno-oruen-cos@naj).
The Childhood Brain Tumor Foundation (CBTF) is soliciting grant applications for the calendar year 2006. Grant sums will be awarded for up to a two-year period, at a maximum of up to $25,000 per year. CBTF accepts grant applications from everywhere in the greater United States. Grant applications may be submitted from researchers who have not received funding from the NIH. All proposed studies must have the approval of the proposing institution’s announcements Institutional Review Board (if appropriate) at the time of funding. Further details on the evaluation criteria, grant application requirements, and grant submission and award are available at the CBTF Web site (www.childhoodbraintumor.org). Grants applications must be received before or on the deadline date of Friday, April 14, 2006.
The Brain Tumor Society is awarding grants to fund basic scientific and translational research directed at finding a cure for brain tumors. One-year $100,000 grants and two-year $200,000 grants are available in the United States and Canada. Grants are awarded annually at a maximum of $100,000 per year and may be used for start-up projects or supplementary funding. Funds cannot be used for indirect costs, and clinical projects will not be funded. The application deadline is March 16, 2006. Application packets are available at the BTS Web site (www.tbts.org).
The Twelfth Annual Neuro-Oncology/Blood-Brain Barrier Consortium Meeting will be held March 23–25, 2006, at Sunriver Resort near Bend, Oregon. Sunriver is a four-diamond resort located in the high desert of Central Oregon, near the Deschutes wilderness area and approximately 18 miles from Mt. Bachelor. The focus of the meeting will be translational research in neuro-oncology and/or the blood-brain barrier. The meeting is partially funded by an R13 meeting grant from the NCI, NINDS and NIDCD.
Contact: Edward A. Neuwelt, Blood-Brain Barrier and Neuro-Oncology Program, Oregon Health and Science University Portland, Oregon
Telephone: Aimee MacKillop, 503-494-0135, Nancy Doolitttle, 503-494-5626
Web Site: www.ohsu.edu/bbb/meeting2006
The British Neuro-Oncology Society will meet at Queen Square, London, June 21–23.
Contact: Dr. David Jellinek, Honorary Secretary, British Neuro-Oncology Society, Royal Hallamshire Hospital, Sheffield, UK
The seventh congress of the EANO will take place at the historic Hofburg Palace (www.hofburg.com), one of Vienna’s finest congress centers. The meeting will include, in addition to the main program, a teaching course and a number of meet-the-expert sessions covering many aspects of the wide field of neuro-oncology. Deadlines are as follows: abstract submission, February 28, 2006; early registration, May 31, 2006; and late registration, August 31, 2006. The local organizer is Prim. Univ. Prof. Dr. Wolfgang Grisold ( firstname.lastname@example.org).
Secretariat: EANO-VII Conference Secretariat, Vienna Medical Academy
The eleventh annual meeting of the Society for Neuro-Oncology will be held in Orlando, Florida.